Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260936 · ClinicalTrials.gov registry record
Metabolic Abnormalities - HIV Infected and Uninfected Males
A clinical trial of HIV Infections, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 250
- Enrollment target
- 13
- Study locations
NCT00260936 is a study of HIV Infections that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 250 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The trial reports 13 study locations across 8 states.
The verdict
NCT00260936, a study of HIV Infections, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 13
- Study locations
Study Summary
To assess whether there exist significant differences in glucose metabolism, lipids, lactate, body composition, and bone density between HIV-infected and uninfected young men.
Conditions Studied
Study Locations (13)
California
- Childrens Hospital of Los Angeles - Los Angeles
- University of California at San Diego - San Diego
- University of California at San Francisco - San Francisco
Florida
- Children's Diagnoistic and Treatment Center - Fort Lauderdale
- University of Miami - Miami
- University of South Florida - Tampa
New York
- Mount Siani Medical Center - New York
- Montefiore Medical Center - The Bronx
District of Columbia
- Childrens Hopital National Medical Center - Washington D.C.
Illinois
- Stroger Hospital of Cook County - Chicago
Massachusetts
- Children's Hopsital of Boston - Boston
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Other
- University Pediatric Hospital - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260936
The ClinicalTrials.gov registry entry for NCT00260936 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00260936 reports 13 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT00260936 about?
NCT00260936 is a clinical study titled "Metabolic Abnormalities - HIV Infected and Uninfected Males". To assess whether there exist significant differences in glucose metabolism, lipids, lactate, body composition, and bone density between HIV-infected and uninfected young men.
What is the current status of trial NCT00260936?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2006-03. Estimated completion is 2007-08.
What conditions does trial NCT00260936 study?
This clinical trial studies the following conditions: HIV Infections.
Who is sponsoring clinical trial NCT00260936?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260936 being conducted?
This trial has 13 study locations across California, District of Columbia, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.